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Summary
Inactivation of presynaptic CaV2.2 channels may play
a role in regulating short-term synaptic plasticity.
Here, we report a direct modulation of CaV2.2 channel
inactivation properties by 14-3-3, a family of signaling
proteins involved in a wide range of biological pro-
cesses. The structural elements critical for 14-3-3
binding and channel modulation lie in the carboxyl
tail of the pore-forming a1B subunit, where we have
identified two putative 14-3-3 interaction sites, includ-
ing a phosphoserine-containing motif that directly
binds to 14-3-3 and a second region near the EF
hand and IQ domain. In transfected tsA 201 cells,
14-3-3 coexpression dramatically slows open-state
inactivation and reduces cumulative inactivation of
CaV2.2 channels. In hippocampal neurons, interference
with 14-3-3 binding accelerates CaV2.2 channel inacti-
vation and enhances short-term synaptic depression.
These results demonstrate that 14-3-3 proteins are im-
portant regulators of CaV2.2 channel activities and
through this mechanismmay contribute to their regula-
tion of synaptic transmission and plasticity.
Introduction
The CaV2.2 channel, along with the CaV2.1 channel,
plays a central role in neurotransmitter release by medi-
ating Ca2+ influx at nerve terminals (Wheeler et al., 1994;
Dunlap et al., 1995; Catterall, 1998; Ertel et al., 2000). As
these Ca2+ channels determine the amount, timing, and
location of Ca2+ influx, evoked neurotransmitter release
can be profoundly affected by changes in channel bio-
physical properties, including activation and inactiva-
tion kinetics (Forsythe et al., 1998; Xu and Wu, 2005).
In particular, CaV2.2 channels exhibit cumulative inacti-
vation in response to brief, repetitive depolarizations.
This results from a process known as preferential
closed-state inactivation and has a marked impact on
both the fidelity of synaptic transmission and short-
term synaptic plasticity (Patil et al., 1998; Thaler et al.,
2004).
Ca2+ channels are capable of undergoing different
types of inactivation that are dependent on either trans-
membrane voltage or intracellular Ca2+. While recent ad-
vances have identified the association of calmodulin as
*Correspondence: yizhou@uab.edua likely mediator for Ca2+-dependent inactivation, much
less is known regarding the molecular mechanism un-
derlying voltage-dependent inactivation, as it not only
involves multiple structural elements of the pore-
forming a1 subunit, but is also modulated by the auxiliary
subunits (Zhang et al., 1994; Budde et al., 2002; Liang
et al., 2003; Chen et al., 2004; Stotz et al., 2004).
In vivo, native CaV2.2 channel currents exhibit a great
variability in their inactivation kinetics: their open-state
inactivation time constants vary from less than 100 ms
to 1.5 s among different types of neurons (Nooney
et al., 1997). Because the pore-forming subunit of
CaV2.2 channels is encoded by a single gene, the kinetic
variability in neurons is attributed to differences in alter-
native splicing of the a1 subunit, association of a1 with
different auxiliary subunits, or modulation by associated
regulatory proteins (Degtiar et al., 2000; Jones, 2003).
We report here that inactivation properties of CaV2.2
channels are profoundly modulated by 14-3-3 proteins.
The 14-3-3 proteins consist of a family of seven homol-
ogous isoforms denoted a, g, 3, h, z, s, and t. They bind
to targets containing specific phosphoserine motifs and
participate in the regulation of a wide range of biological
processes (Fu et al., 2000; Tzivion and Avruch, 2002). In
the nervous system, 14-3-3 proteins are abundantly
expressed in the brain, comprising approximately 1%
of its total soluble proteins, and some 14-3-3 isoforms
are particularly enriched in the synapses of central and
peripheral neurons. However, the precise physiological
function of 14-3-3 proteins in neurons is largely un-
known (Berg et al., 2003). Previously, we have identified
14-3-3z as a part of a protein complex that regulates the
activity of the Ca2+-dependent potassium channel (dSlo)
in the fruit fly Drosophila. 14-3-3z interacts with dSlo
through its association with a dSlo-binding protein,
Slob. When assayed electrophysiologically, dSlo activ-
ity is dramatically decreased by 14-3-3z, acting via
Slob. Since dSlo currents contribute to membrane repo-
larization and help to limit neurotransmitter release from
presynaptic terminals, inhibition of dSlo activity by
14-3-3z, via its binding to Slob, may lead to an enhance-
ment of synaptic transmission at the Drosophila neuro-
muscular junction (Schopperle et al., 1998; Zhou et al.,
1999). This is consistent with the reduction in synaptic
transmission observed in 14-3-3z mutant flies (Broadie
et al., 1997).
In the vertebrate nervous system, a regulatory protein
complex comparable to that of the Drosophila dSlo/
Slob/14-3-3 has not yet been established (Mao et al.,
2005). In search for other 14-3-3-binding proteins
that are important in regulating neuronal function, we
have discovered a protein-protein interaction between
14-3-3 and the CaV2.2 channel in the brain. In this study,
we performed a detailed analysis of both the biochemi-
cal basis of the protein-protein interaction and the mod-
ulatory effect of 14-3-3 on CaV2.2 channels. Our findings
set a stage for further determination of the molecular de-
tail of the 14-3-3/CaV2.2 channel regulatory complex
and provide a foundation to investigate 14-3-3’s func-
tions in the nervous system.
Neuron
756Figure 1. Interaction between 14-3-3 and
CaV2.2 Channels
(A) Immunofluorescence images of cultured
rat hippocampal neurons labeled with anti-
bodies specific to the a1B subunit or a partic-
ular isoform of 14-3-3 proteins. Arrowhead
indicates staining at synaptic regions. The
14-3-3 antibodies are specific for each of
the 14-3-3 isoforms.
(B) Confocal images of cultured rat hippo-
campal neurons double labeled with the
anti-Synapsin I antibody together with either
anti-a1B subunit (top panel) or anti-14-3-3g
(bottom panel) antibodies. Both a1B subunits
and 14-3-3g colocalize extensively with Syn-
apsin I at presynaptic regions.
(C) a1B subunits and 14-3-3 coimmunopreci-
pitate from rat brain. The a1B subunit is recog-
nized in all five isoform-specific 14-3-3 immu-
noprecipitates (lanes 1–5). a1B proteins are
present in lysates prepared from rat brain
(lane 6), but not from rat pancreas (lane 7).
(D) a1B subunits coimmunoprecipitate with
several 14-3-3 isoforms from cotransfected
tsA 201 cells. 1D4-tagged 14-3-3 proteins
were immunoprecipitated with anti-1D4 anti-
body. A similar amount of a1B subunits is
present in 1D4 immunoprecipitates from cells
cotransfected with CaV2.2 channel subunits
and each of the 14-3-3 isoforms (lanes 1–6,
top panel), but not from vector-cotransfected
cells (lane 7). Expressions of a1B subunits and
1D4 epitope-tagged 14-3-3 proteins were
comparable (middle and bottom panels).Results
14-3-3 Interacts with CaV2.2 Channels in Rat Brain
InDrosophila, 14-3-3z proteins are enriched at nerve ter-
minals and involved in regulating synaptic transmis-
sions at the neuromuscular junction (Broadie et al.,
1997). To determine the subcelluar localizations of
14-3-3 proteins in vertebrate neurons, we immuno-
stained cultured rat hippocampal neurons with anti-
bodies specific for each of six 14-3-3 isoforms that are
known to be expressed in the brain. Immunoreactivity
for all 14-3-3 isoforms was dispersed throughout the
somata and neurites. In synaptically matured neurons,
however, there was enhanced punctate staining in
the neurites for several 14-3-3 isoforms, including
14-3-3a, -g, and -z (Figure 1A), suggesting that 14-3-3
is enriched at synapses.14-3-3 functions by binding to its target proteins. To
search for proteins that might interact with 14-3-3 in
neurons, we immunoprecipitated 14-3-3 proteins from
lysates of crude rat brain membranes using 14-3-3 anti-
bodies and probed the 14-3-3 immunoprecipitates on
western blots using a panel of antibodies for synapti-
cally enriched proteins, including several classes of ion
channels and receptors. Among them, an antibody
specific for the pore-forming a1B subunit of the CaV2.2
channel recognizes a protein band of w220 kDa in
14-3-3 immunoprecipitates. The same band is detected
by two separate a1B antibodies and is absent in the
membranes prepared from rat pancreas, which does
not express the a1B subunit (Figure 1C). These data
confirm that it is indeed the a1B subunit that associates
with 14-3-3. To identify the potential subcellular site of
interaction between 14-3-3 and CaV2.2 channels, we
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with either the 14-3-3g or a1B antibody, together with
the synapsin I antibody that specifically labels the pre-
synaptic terminals (Sudhof and Jahn, 1991). Although
both 14-3-3g and a1B subunits distribute broadly in
both the somata and neurites, they exhibit extensive
costaining with synapsin I in presynaptic terminals
(Figure 1B), suggesting that this protein complex may
be present in presynaptic terminals and play a role in
regulating synaptic transmissions.
14-3-3 Binds to the Carboxyl-Terminal Tail
of the a1B Subunit
To examine the molecular details of the interaction be-
tween 14-3-3 and the CaV2.2 channel, we first tested
the ability of different 14-3-3 isoforms to bind the
CaV2.2 channel. In these experiments, major subunits
of the CaV2.2 channel (a1B, b1b, and a2d) were coex-
pressed with one of the six isoforms of 14-3-3 proteins
in tsA 201 cells. To ensure analogous immunoprecipita-
tions of different 14-3-3 isoforms, exogenously ex-
pressed 14-3-3 proteins were immunoprecipitated with
the anti-1D4 antibody that recognized a 1D4 epitope
tagged to all the 14-3-3 isoforms (Oprian et al., 1991).
As shown in Figure 1D, a comparable amount of a1B sub-
unit is present in 14-3-3 immunoprecipitates from all
14-3-3-cotransfected cells, but not from vector-cotrans-
fected cells, demonstrating that these 14-3-3 proteins
are all capable of binding to CaV2.2 channels.
CaV2.2 channels are heteromultimeric proteins
formed by association of several subunits (Catterall,
2000) (Figure 2A). In the absence of any coexpressed
auxiliary subunit, the pore-forming a1B subunit coimmu-
noprecipitates with 14-3-3 in cotransfected tsA 201 cells
(Figure 2B, left panel). In contrast, the b1b subunit does
not coimmunoprecipitate with 14-3-3 when only these
two proteins are coexpressed in tsA 201 cells. However,
when a1B subunits are cotransfected with b1b and
14-3-3, b1b subunits are present in 14-3-3 immunopre-
cipitates (Figure 2B, right panel), suggesting that
14-3-3 and the b subunit can simultaneously bind to
the a1B subunit. Taken together, these results demon-
strate clearly that 14-3-3 proteins interact with the
CaV2.2 channel complex via their binding to the a1B
subunit.
To identify potential 14-3-3-binding sites in the a1B
subunit, we cloned the five intracellular fragments of
the a1B subunit into a GST fusion mammalian expression
vector and tested their abilities to bind 14-3-3 in cotrans-
fected tsA 201 cells by coimmunoprecipitation and
western blot analysis. Among these fusion proteins,
the GST-CT exhibits the most robust binding to 14-3-3
(Figure 2C), indicating the presence of high-affinity
14-3-3-binding site(s) in the a1B C-terminal tail. Subse-
quently, we adopted a truncation strategy to identify
potential 14-3-3-binding sites in the a1B C-terminal tail.
As shown in Figure 2D, removal of 193 amino acids (res-
idues 2140–2332) from the COOH terminus does not af-
fect its binding to 14-3-3. However, a further deletion of
18 amino acids (residues 2122–2139) results in a signifi-
cant reduction of 14-3-3 binding, suggesting the pres-
ence of a potential 14-3-3-binding domain in this small
region. Further truncations of GST-CT toward the amino
side of the C-terminal tail gradually decrease its bindingto 14-3-3, and no 14-3-3 binding was detected for GST-
1706-1914 (Figure 2D).
14-3-3 Binding Is Regulated by Phosphorylation
of S2126 of the a1B Subunit
An examination of the amino acid sequence in the puta-
tive 14-3-3-binding site reveals two potential 14-3-3-
binding motifs (Muslin et al., 1996; Yaffe et al., 1997)
(Figure 3A). We therefore examined the participation of
these motifs in 14-3-3 binding by site-directed mutagen-
esis. As shown in Figure 3B, the second motif (RFGS2132)
is not involved in 14-3-3 binding, since mutation of the
key serine residue (S2132A) does not affect the binding
of GST-CT to 14-3-3. However, the interaction between
14-3-3 and GST-CT is significantly reduced in either the
R2123E or S2126A mutant, suggesting that the first
motif (RFYS2126) is a phosphoserine-containing motif
for 14-3-3 binding (Figure 3B, left panel). As this single
mutation (S2126A) also results in a dramatic reduction
in the binding of the full-length a1B subunit to 14-3-3
(Figure 3B, right panel), this motif plays a significant
role in mediating the interaction between 14-3-3 and
CaV2.2 channels.
To directly test whether phosphorylation of S2126 in
the a1B subunit is important for its binding to 14-3-3,
we expressed in and purified from bacteria a small
GST fusion protein containing the putative 14-3-3-bind-
ing motif (residues 2076–2140). The fusion protein was
first in vitro phosphorylated by either calcium/calmodu-
lin-dependent protein kinase II (CaMKII) or cAMP-
dependent protein kinase A (PKA) and subsequently
mixed with recombinant 14-3-3g that was also produced
in and purified from bacteria. The interaction between
recombinant 14-3-3 and the GST fusion protein was
then assessed by coimmunoprecipitation and western
blot analysis. As shown in Figure 3C, only background
level of the GST fusion protein is detected in the
14-3-3 immunoprecipitates when it was not subjected
to in vitro phosphorylation. However, 14-3-3 binding is
markedly enhanced when the fusion protein was phos-
phorylated by either CaMKII or PKA prior to mixing
with 14-3-3. No such enhancement is observed with
the mutant S2126A fusion protein, suggesting that
14-3-3 binding is dependent on phosphorylation of
S2126. In addition, we directly examined phosphoryla-
tion of S2126 by probing the mixture with a sequence-
and phosphorylation-specific antibody, anti-pS2126,
and observed a precise correlation between the extent
of 14-3-3 binding and S2126 phosphorylation (Figure 3C,
top and middle panels). Given that these binding assays
were carried out in a cell-free environment, these results
also provide evidence that 14-3-3 can directly bind to
the a1B subunit via the phosphoserine-containing motif.
Moreover, we cotransfected 14-3-3 and the CaV2.2
channel subunits with either a constitutively active form
of CaMKII, a peptide inhibitor of CaMKII (ala peptide),
or the catalytic subunit of PKA (PKAc), and assessed
their effects on the 14-3-3/CaV2.2 channel interaction.
As shown in Figure 3D, 14-3-3 binding to the wild-type
a1B subunits is increased by coexpression of either
CaMKII or PKAc. Consistent with our in vitro assays (Fig-
ure 3C), CaMKII appears to be more effective than PKAc
in promoting S2126 phosphorylation and 14-3-3 binding.
Conversely, expression of the peptide inhibitor of
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758Figure 2. Molecular Details of the 14-3-3/CaV2.2 Channel Interaction
(A) Schematic diagram showing subunit composition of the CaV2.2 channel and proposed topology for the pore-forming a1B subunit.
(B) 14-3-3 binds directly to the a1B subunit. (Left panel) a1B subunits and 14-3-3 coimmunoprecipitate from cotransfected cells, either in the pres-
ence (left lane) or absence (middle lane) of b1b subunits. (Right panel) b1b subunits coimmunoprecipitate with 14-3-3 from cotransfected cells, but
only in the presence of a1B subunits (right lane). The a2d subunit is not cotransfected at both conditions.
(C) 14-3-3 binds most strongly to the carboxyl-terminal tail of the a1B subunit. When 14-3-3 is cotransfected with each of five GST-fused intra-
cellular domains (bottom panel) in tsA 201 cells, only GST-CT is robustly coimmunoprecipitated with 14-3-3 (top panel).
(D) Deletion analysis reveals regions in the a1B C-terminal tail that are critical for 14-3-3/channel interaction. (Left panel) Schematic diagram sum-
marizes the effects on 14-3-3 binding of progressive truncations of the a1B C-terminal tail. The critical 14-3-3-binding site in GST-CT is indicated
by a black box. (Right panel) Representative western blots illustrate binding of 14-3-3 to various GST-CT fragments.CaMKII decreases the 14-3-3/channel interaction. Since
no analogous change in 14-3-3 binding is observed with
the mutant S2126A a1B subunit (Figure 3D, bottom
panel), these results demonstrate that interactions be-
tween 14-3-3 and CaV2.2 channels can be regulated by
phosphorylation of S2126 in cells.
14-3-3 Modulates Inactivation Properties
of the CaV2.2 Channel
To examine the effect of 14-3-3 on the biophysical prop-
erties of CaV2.2 channels, we recorded Ca
2+ channel
currents from transfected tsA 201 cells and assessed
changes in channel properties induced by exogenously
expressed 14-3-3 proteins. In these experiments,
whole-cell CaV2.2 channel currents were elicited by de-polarizing voltage steps from a holding potential of 280
mV, using Ba2+ as the charge carrier (IBa). As is clearly
evident from the comparison of macroscopic IBa traces,
the inactivation kinetics of IBa is considerably slower in
tsA 201 cells coexpressed with 14-3-33 than that in con-
trol cells (Figure 4A). A similar decrease in open-state in-
activation of CaV2.2 channels was observed in cells
coexpressed with other 14-3-3 isoforms. However, the
extent of change in IBa inactivation is different among
various isoforms of 14-3-3 (Figure 4B). As an index of
the open-state IBa inactivation, we measured the ampli-
tude of whole-cell currents at the end of a 400 ms test
pulse and normalized it to the peak current (R400). As
shown in Figure 4C, coexpression of 14-3-3 proteins
slows channel inactivation kinetics over the entire
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759Figure 3. Regulation of the 14-3-3/CaV2.2
Channel Interaction by Phosphorylation
(A) Schematic diagram showing relative posi-
tions of EF hand, PreIQ3 + IQ, and the critical
14-3-3-binding domain. The two potential
14-3-3-binding motifs within the site are
underlined.
(B) Site-directed mutagenesis reveals a
14-3-3-binding motif. (Left panel) 14-3-3
coimmunoprecipitates with the wild-type
and S2132A GST-CT but binds less well to
R2123E or S2126A GST-CT (top panel). Ex-
pression of all GST fusion proteins is equal
under these conditions (bottom panel). (Right
panel) The S2126A mutation of the full-length
a1B subunit dramatically decreases its bind-
ing to 14-3-3.
(C) 14-3-3 directly binds to the phosphoser-
ine motif on the a1B C-terminal tail. Wild-
type GST fusion proteins containing the
putative 14-3-3-binding motif (aa 2076–
2140) were in vitro phosphorylated at S2126
by either CaMKII or PKA, as detected by
the sequence- and phosphorylation-specific
antibody, anti-pS2126 (middle panel). Phos-
phorylation of S2126 significantly increases
its binding to recombinant 14-3-3g (top
panel). No such effect is seen with the
S2126A mutant fusion protein (right panels).
(D) 14-3-3 binding to CaV2.2 channels is
promoted by phosphorylation. 14-3-3 and
channel subunits were cotransfected with
CaMKII, the ala peptide, or PKAc in tsA201
cells. 14-3-3-bound wild-type (top panel) or
S2126A mutant (bottom panel) a1B proteins
were assessed on western blots.activation voltage range. To quantify the changes of
channel open-state inactivation induced by different
isoforms of 14-3-3, we compared their R400 values at
two test voltages. Among the five 14-3-3 isoforms tested
in this study, the largest change is observed with coex-
pression of 14-3-33, -t, or -g, while a smaller change is
induced by 14-3-3a or -z (Figure 4D).
We also analyzed the inactivation kinetics of CaV2.2
channels by fitting the inactivation component of the
whole-cell current traces. In the majority of cells trans-
fected with only the CaV2.2 channel subunits, the decay
of IBa evoked by a +30 mV test pulse was best fitted by
a double exponential function. With cotransfection of
14-3-3, however, the decay of IBa in most cells becomes
better fitted by a single exponential function (Table 1A).
Hence, we assessed the 14-3-3-induced changes in in-
activation kinetics by comparing separately the groups
that exhibit single or biphasic inactivation to their
respective controls. For IBa that decays with a single ex-ponential function, the inactivation time constant (t) is
significantly larger in tsA 201 cells cotransfected with
14-3-33, -t, or -g (Table 1A). For biphasically inactivated
IBa, coexpression of all five 14-3-3 isoforms significantly
increases the time constant of the fast component (tfast),
while the slow component (tslow) is significantly in-
creased by three isoforms of 14-3-3 (3, t, and g) (Table
1B). Together, these results are consistent with the
R400 analyses described above.
Moreover, 14-3-3 decreases the voltage dependence
of CaV2.2 closed-state inactivation. This was deter-
mined by assessing channel availability after a long
(10 s) prepulse voltage steps. As shown in Figure 4E,
the inactivation curve of CaV2.2 channels is shifted to
the right by coexpressed 14-3-3. Collectively, three of
the five 14-3-3 isoforms cause a significant increase
in the voltage required for half-maximal inactivation
(V1/2), and the largest shift in V1/2 is nearly +10 mV by
14-3-33 (Figure 4F).
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760Figure 4. Modulation of Open- and Closed-State Inactivations of CaV2.2 Channels by 14-3-3 in Cotransfected tsA201 Cells
(A) Representative whole-cell IBa traces from cells transfected with the major subunits for CaV2.2 channels, either alone (left) or together with
14-3-33 (right).
(B) Slowing of IBa fast inactivation at open state by coexpressed 14-3-3 proteins. Representative current traces were normalized and aligned to
show the effect of different isoforms of 14-3-3. Color coding of various transfection conditions is the same as in Figure 4C.
(C) Changes of IBa open-state inactivation induced by each of the five 14-3-3 isoforms at different test potentials, as measured by the relative
residual current amplitude at the end of a 400 ms test pulse (R400, mean 6 SEM).
(D) Summary of the effect of the five 14-3-3 isoforms on open-state inactivation of IBa, as compared by their R400 value at both +25 and +30 mV
(***p < 0.0001, ANOVA, Tukey’s test).
(E) Changes in voltage dependence of closed-state inactivation by coexpressed 14-3-3 proteins, determined by measuring peak current ampli-
tude during a 50 ms test pulse to +20 mV, following a series of 10 s prepulse voltage steps in 10 mV increments from a holding potential
of 280 mV.
(F) Summary of the effect of the five 14-3-3 isoforms on closed-state inactivation of IBa. Half-inactivation voltages (V1/2, mean 6 SEM) were de-
termined from Boltzmann fits of the inactivation I/Imax as a function of prepulse voltage at different transfection conditions (*p < 0.01, **p < 0.001,
ANOVA, Tukey’s test).CaV2.2 channels do not exhibit marked Ca
2+-depen-
dent inactivation in a1B-, b1b-, and a2d-cotransfected
tsA 201 cells (Liang et al., 2003). When Ca2+, instead
of Ba2+, was used as the charge carrier, coexpression
of 14-3-3 also significantly slowed inactivation kinetics
of the macroscopic currents, as analyzed by both R400
and inactivation time constants (data not shown). To fur-
ther examine 14-3-3’s effect on various aspects of
CaV2.2 channel inactivation properties, we measured
whole-cell currents elicited by a test pulse to +20 mV
followed by a series of short (400 ms) prepulse steps
(Figure 5A). Using this protocol, we first determined
that coexpression of 14-3-3 does not alter voltage-dependent activation of CaV2.2 channels, since no
difference was observed in normalized I-V relationship
between control and 14-3-3-cotransfected cells when
either Ca2+ or Ba2+ was used as the charge carrier
(Figure 5A, activation curves). In addition, we assessed
the effect of 14-3-3 on the short prepulse-induced
inactivation of CaV2.2 channels. Similar to previous
reports, the prepulse-dependent inactivation exhibits
a ‘‘U-shaped’’ relationship. Since the inactivation
curve is similar for both Ca2+ and Ba2+ currents, this
‘‘U-shaped’’ inactivation likely reflects a joint effect of
both open- and preferential closed-state inactivation,
but not Ca2+-dependent inactivation of CaV2.2 channels
Bound 14-3-3 Modulates CaV2.2 Channels
761Table 1. Kinetics of IBa Open-State Inactivation at +30 mV
(A) Time Constants of Monophasic Inactivation
Transfection: a1B/b1b 2 a2d + t (ms) p value versus control t n
Vector (control) 124 6 5.19 — 22
14-3-3g 228 6 11.23 <0.0001 35
14-3-33 170 6 7.62 <0.0001 26
14-3-3t 198 6 16.18 <0.00001 9
14-3-3a 135 6 7.49 >0.05 17
14-3-3z 140 6 7.01 >0.05 17
(B) Time Constants of Biphasic Inactivation
Transfection: a1B/b1b 2 a2d + t1 (ms) p value versus control t1 t2 (ms) p value versus control t2 n
Vector (control) 58 6 3.02 — 207 6 14.44 — 64
14-3-3g 83 6 21.50 <0.05 678 6 216.44 <0.00001 9
14-3-33 126 6 10.67 <0.00001 929 6 185.80 <0.00001 16
14-3-3t 90 6 10.21 <0.001 1158 6 256.73 <0.00001 15
14-3-3a 84 6 9.53 <0.01 245 6 28.99 >0.05 10
14-3-3z 73 6 6.01 <0.05 302 6 46.96 <0.05 24
Inactivation time constants were estimated by fitting the inactivation component of the current trace using the following equations: I = I exp(2t/t)
in (A); I = I0 + I1 exp(2t/t1) + I2 exp(2t/t2) in (B). I0 is the residual current amplitude at equilibrium; I1 and I2 are the amplitudes of the fast and slow
components, respectively. Values are expressed as mean 6 SEM.(Patil et al., 1998). Consistent with our finding that 14-3-3
modulates CaV2.2 channel inactivation at various states,
coexpression of 14-3-3g reduces the prepulse-depen-
dent inactivation at almost all voltages, as evidenced
by a considerable shift of the inactivation curves for
both IBa and ICa (Figure 5A).
Furthermore, we directly tested the effect of 14-3-3 on
preferential closed-state inactivation of the CaV2.2
channel by examining cumulative inactivation of macro-
scopic CaV2.2 channel currents. In these experiments,
whole-cell Ba2+ currents were elicited by a train of brief
depolarizing pulses. As shown in Figure 5B, IBa inacti-
vates much more slowly and to a lesser degree with co-
expression of 14-3-33. A significant reduction in channel
cumulative inactivation was also observed for two other
14-3-3 isoforms (g and t) examined in this study
(Figure 5C). In addition, we explored whether the effect
of 14-3-3 varies with changes in either test pulse dura-
tion or frequency. Our results show that coexpression
of 14-3-3 significantly decreases cumulative inactivation
of CaV2.2 channels evoked by various durations of test
pulse (Figure 5D) and delivered at different frequencies
(Figure 5E).
14-3-3 Selectively Modulates Other Subtypes
of Ca2+ Channels
To determine the specificity of 14-3-3’s modulation on
the CaV2.2 channel, we coexpressed 14-3-3 with one
of the other four subtypes of voltage-dependent Ca2+
channels in tsA 201 cells and carried out electrophysio-
logical experiments similar to those described above.
As shown in Figures 6A and 6B, coexpression of
14-3-3g significantly slows inactivation kinetics of
CaV2.3 channels. In contrast, inactivation kinetics of
the other three subtypes of Ca2+ channels is not affected
by exogenously expressed 14-3-3, as assessed by com-
paring R400 (for CaV1.2 and CaV2.1) or tinact (for CaV3.1)
between control and 14-3-3g-cotransfected cells (Fig-
ures 6A and 6B). Thus, 14-3-3-dependent modulation
is specific for the CaV2.2 and CaV2.3 channels.14-3-3 Alters the Intrinsic Inactivation Properties
of the a1B Subunit through Its Binding
To investigate the mechanism of 14-3-3-dependent
modulation, we first asked whether 14-3-3 slows chan-
nel inactivation by impeding the b1b subunit dependent
acceleration (Dolphin, 2003). In these experiments,
whole-cell Ba2+ currents were recorded from tsA 201
cells transfected only with the a1B subunit. Similar to
previous reports (Yasuda et al., 2004), IBa recorded
from these cells has a substantially smaller peak ampli-
tude and moderately slower open-state inactivation
than that recorded from the b1b subunit-cotransfected
cells (Figure 6C, compared to Figure 4A). However, co-
expression of 14-3-3 in these cells leads to a consider-
able further slowing of channel open-state inactivation
(Figures 6C and 6D). A significant slowing of channel in-
activation by coexpressed 14-3-3 was also observed in
cells cotransfected with a1B and a2d, but not b1b sub-
units (data not shown). Together, these results demon-
strate that 14-3-3 modulates CaV2.2 channels by directly
altering the intrinsic inactivation properties of the a1B
subunit.
Next, we tested whether 14-3-3 binding is necessary
for its modulation of CaV2.2 channels. Our strategy is
to disrupt 14-3-3/ligand interactions in cells by express-
ing a previously characterized high-affinity 14-3-3 ago-
nist (the R18 peptide) (Wang et al., 1999). We confirmed
that the R18 peptide reduces 14-3-3 binding to either
GST-CT or a1B subunits in a dose-dependent manner
(Figure S1A in the Supplemental Data available with
this article online). In tsA 201 cells, binding of a1B to
14-3-3 is almost completely inhibited by cotransfection
of the R18 peptide-containing plasmid, pSCM138, but
not affected by its control plasmid, pSCM174, which
expresses an inactive mutant peptide (Figure S1B).
When assayed electrophysiologically, coexpression of
pSCM138, but not pSCM174, significantly accelerates
open-state inactivation of CaV2.2 channels in cells
cotransfected with 14-3-3 (Figure 7A). As analyzed by
R400, the extent of IBa inactivation in pSCM138-,
14-3-3-, and CaV2.2 channel-cotransfected cells is
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(A) 14-3-3 does not alter voltage-dependent activation but similarly decreases prepulse-dependent inactivation of CaV2.2 channels with either
Ba2+ or Ca2+ as the charge carrier. Inactivation curves were generated by plotting relative peak current amplitude during a 400 ms test pulse to
+20 mV, following a series of 400 ms prepulse voltage steps in 10 mV increments from a holding potential of 280 mV. Activation curves were
constructed by plotting the relative peak current amplitude evoked at different prepulse potentials.
(B) Representative current traces from cells transfected with the major subunits of CaV2.2 channels, either alone (top) or together with 14-3-33
(bottom). Currents were elicited by a train of 5 ms depolarizations to +20 mV, delivered at 20 Hz from a holding potential of 280 mV.
(C) Summary of the effect of three 14-3-3 isoforms on cumulative inactivation of IBa, measured as the ratio between currents evoked by the last
and the first stimulus in a 1 s train (Ilast/I1st, mean 6 SEM) (**p < 0.001, ANOVA, Tukey’s test).
(D and E) Reduction in IBa cumulative inactivation by 14-3-3 is not dependent on the depolarization duration or frequency. Currents were evoked
by trains of test pulses to +20 mV. The stimulus frequency is 20 Hz in (D), and the duration of the depolarizing pulse is 20 ms in (E) (*p < 0.05,
**p < 0.001, Student’s t test).similar to that recorded from cells without exogenously
expressed 14-3-3 (Figure 7B, compared to Figures 4D or
7D), showing that the modulation is completely abol-
ished by interference with 14-3-3 binding. Moreover,
in the absence of exogenous 14-3-3, expression of
pSCM138 in tsA 201 cells further accelerates inactiva-
tion kinetics of the CaV2.2 channel (Figures 7C and7D), revealing modulations conferred by endogenous
14-3-3 proteins in tsA 201 cells (Jin et al., 2004).
Modulation of the CaV2.2 Channel Is Mediated
by 14-3-3 Binding to the a1B C-Terminal Tail
To directly establish that 14-3-3 modulates CaV2.2
channels through its binding to the channel, we first
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(A) Representative whole-cell currents from tsA 201 cells transfected with the major subunits of CaV1.2 (L-type), CaV2.1 (P/Q-type), CaV2.3
(R-type), and CaV3.1 (T-type) channels, either alone (dark trace) or together with 14-3-3g (gray trace).
(B) Open-state inactivation of CaV1.2, CaV2.1, or CaV3.1 is not significantly altered by cotransfected 14-3-3g, as measured by either R400 or
inactivation time constant tinact (mean6 SEM) at two test potentials (Student’s t test, p > 0.5). However, CaV2.3 channels inactivate significantly
slower in tsA 201 cells cotransfected with 14-3-3g (**p < 0.01, Student’s t test).
(C) Representative whole-cell currents from tsA 201 cells transfected with the a1B subunits, either alone (dark trace), or together with 14-3-33
(gray trace) or 14-3-3g (light gray trace).
(D) In the absence of any exogenous auxiliary subunit, cotransfection of either 14-3-33 or -g significantly slows IBa open-state inactivation, as
measured by R400 (mean 6 SEM) at both +25 and +30 mV (***p < 0.0001, ANOVA, Tukey’s test).determined whether the modulation requires the a1B
C-terminal tail, to which 14-3-3 binds most strongly
(Figure 2C). Since 14-3-3 does not modulate the
CaV1.2 channel, we generated a chimeric subunit (a1B-
CTa1C) by replacing the majority of a1B C-terminal tail
(residues 1761–2332; Figure 3A) with corresponding se-
quences of the a1C subunit (residues 1529–2171). When
expressed in tsA 201 cells, neither open-state nor cumu-
lative inactivation of the a1B-CTa1C chimeric channel is
significantly affected by coexpressed 14-3-3 (Figures
7E and 7F), suggesting that the a1B carboxyl tail is the
major structural determinant for 14-3-3-dependent
modulation of the CaV2.2 channel.
Next, we tested the functional involvement of the
phosphoserine-containing motif by examining the
mutant S2126A a1B subunit. As shown in Figure 8A,although open-state inactivation of the mutant S2126A
channel is slowed by exogenously expressed 14-3-3,
the extent of changes induced by coexpressed 14-3-3
is significantly less for the S2126A mutant than the
wild-type channel (Figures 8A and 8B). These data are
consistent with our biochemical data showing a reduced
binding of 14-3-3 to the S2126A a1B subunit (Figure 3B)
and indicate that 14-3-3 binding to this phosphoserine-
containing motif (site 1) contributes to its modulation of
CaV2.2 channels (Figure 8F).
To identify the other potential 14-3-3-binding site(s) in-
volved in channel modulation, we generated several
mutant a1B subunits that are truncated at the region of
the carboxyl tail more proximal to the phosphoserine-
containing motif. These include truncations at positions
K2121, R2112, K2019, Q2009, or Q1914. In our in vitro
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(A) Representative whole-cell currents from tsA 201 cells cotransfected with CaV2.2 channels and 14-3-3g (dark trace), or together with pSCM138
(light gray trace) or pSCM174 (gray trace).
(B) Cotransfection of pSCM138, but not pSCM174, significantly decreases R400 (mean 6 SEM) at both +25 and +30 mV (*p < 0.05, ANOVA,
Tukey’s test).
(C) Representative whole-cell currents from tsA 201 cells transfected with CaV2.2 channels, either alone (dark trace), or together with pSCM138
(light gray trace) or pSCM174 (gray trace).
(D) In the absence of exogenous 14-3-3, R400 (mean 6 SEM) at both +25 and + 30 mV is further decreased by cotransfection of pSCM138
(**p < 0.01, ANOVA, Tukey’s test).
(E) Representative whole-cell currents from tsA 201 cells transfected with the chimeric subunit a1B-CTa1C, either alone (dark trace) or together
with 14-3-3g (gray trace).
(F) 14-3-3gdoes not affect either open-state or cumulative inactivation of the chimeric Ca2+ channel, as measured by R400 at two test potentials or
Ilast/I1st in a 20 Hz train of depolarizations to +20 mV (mean 6 SEM) (p > 0.5, Student’s t test).binding assay, truncations at these corresponding
positions further reduce or abolish 14-3-3 binding to
the GST-CT fusion protein (Figure 2D), indicating the
presence of a potential 14-3-3-binding site in the region
between residues Q1914 and K2121. Surprisingly,
when transfected into tsA 201 cells, these truncation mu-
tant channels exhibit an apparent modulation of channel
inactivation by coexpressed 14-3-3 (Figure 8D). Like-
wise, as assessed by coimmunoprecipitation and west-
ern blot analysis, 14-3-3 binding to the channel is not
significantly affected by truncations within this region
(Figure 8E).In light of this finding, we hypothesized that the sec-
ond site that is important for 14-3-3 binding and modu-
lation is localized near the amino side of the carboxyl tail
(more proximal to residue Q1914), which might have
been overlooked in our binding assays using truncated
GST-CT fusion proteins (see Discussion). We therefore
further truncated the a1B subunit at residue A1811,
P1834, or G1872. Among the three mutants, only the
G1872X a1B subunit expresses macroscopic Ca
2+ chan-
nel currents in transfected tsA 201 cells. As shown in
Figures 8C and 8D, although the mutant G1872X channel
inactivates slower than either the wild-type or other
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(A) Representative currents were normalized and aligned to compare the 14-3-3-induced slowing of open-state inactivation for the wild-type
(dark traces) and mutant S2126A (gray traces) channels.
(B) Although 14-3-3 slows inactivation of the mutant S2126A channel, the extent of the increase in R400 (mean6 SEM) by two 14-3-3 isoforms is
significantly less in cells cotransfected with the S2126A a1B subunits, compared to the wild-type channel (*p < 0.05, **p < 0.01, Student’s t test).
(C) Representative whole-cell currents from tsA 201 cells transfected with one of the C-terminal truncated mutant a1B subunits, G1872X, either
alone (dark trace) or together with 14-3-3g (gray trace).
(D) Cotransfection of 14-3-3g does not significantly change open-state inactivation of the mutant G1872X a1B subunit, as measured by R400
(mean 6 SEM) at +25 mV (p > 0.13, Student’s t test). However, 14-3-3g significantly slows inactivation of other mutants that are truncated at
more distal positions of the a1B subunit (**p < 0.01, Student’s t test).
(E) 14-3-3 retains weak binding to mutant a1B subunits truncated in a region between residues Q1914X and K2121 (top panel, lanes 3–5). A further
truncation at the amino side of the carboxyl tail (G1872X) nearly eliminates 14-3-3 binding to the a1B subunit (top panel, lane 2).
(F) Schematic diagram showing the two putative 14-3-3-binding sites involved in channel modulation. The arrow indicates that the molecular
detail for 14-3-3 binding to site 2 has not been completely determined.mutants with truncations at more distal locations, its in-
activation kinetics is no longer affected by coexpressed
14-3-3. In addition, we find only a very weak interaction
between 14-3-3 and the mutant G1872X a1B subunit,
suggesting the involvement of the small region between
residues G1872 and Q1914 in mediating 14-3-3 binding
to the channel (Figure 8E, top panel). Taken together, al-
though these results may not be sufficient to establish
a direct binding of 14-3-3 to this small region (see
Discussion), they demonstrate that 14-3-3-dependent
modulation correlates with 14-3-3 binding to the a1B
subunit and support our hypothesis that the second14-3-3-binding site is localized at the proximal region
of the a1B carboxyl tail (site 2; Figure 8F).
14-3-3 Modulates CaV2.2 Channel Inactivation
in Neurons
To investigate whether 14-3-3 modulates CaV2.2 chan-
nels in neurons, we carried out experiments in cultured
rat hippocampal neurons, in which both CaV2.2 chan-
nels and 14-3-3 proteins are abundantly expressed (Fig-
ures 1A and 1B). Neurons 7–10 days in vitro (DIV) were
transfected with either the 14-3-3-binding antagonist
pSCM138 or its inactive mutant control, pSCM174.
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tivation by 14-3-3 in Neurons
(A) Representative whole-cell CaV2.2 channel
Ba2+ currents recorded from untransfected
rat hippocampal neurons (dark trace), or neu-
rons transfected with either the high-affinity
14-3-3-binding antagonist pSCM138 (light
gray trace) or its inactive mutant control,
pSCM174 (gray trace).
(B) Transfection of pSCM138, but not
pSCM174, significantly decreases R400
(mean 6 SEM) at both +5 and +10 mV (*p <
0.01, **p < 0.001, ANOVA, Tukey’s test).
(C) Representative whole-cell CaV2.2 channel
Ba2+ currents recorded from untransfected
neurons (top, dark trace), or neurons trans-
fected with either pSCM138 (bottom, light
gray trace) or pSCM174 (middle, gray trace).
Currents were elicited by a train of 10 ms volt-
age pulses to +20 mV, delivered at 20 Hz from
a holding potential of 280 mV.
(D) Effects of disrupting endogenous 14-3-3
binding on cumulative inactivation of CaV2.2
channels, measured as the ratio between cur-
rents evoked by the last and the first stimulus
in a 1 s train (Ilast/I1st, mean 6 SEM) (**p <
0.001, ANOVA, Tukey’s test).Two days following transfection, we recorded endoge-
nous Ca2+ channel currents from these neurons. The
bath solution contained tetrodotoxin (TTX, 1 mM) to
block Na+ channels, and Nifedepine (10 mM) and u-aga-
toxin IVA (200 nM) to block CaV1 and CaV2.1 channels,
respectively. Under these conditions, except for a very
small fraction of CaV2.3 currents, the inward currents
are mediated primarily by CaV2.2 channels. Similar to
what we find in the heterologous expression system,
transfection of either pSCM138 or pSCM174 does not
affect voltage-dependent activation of the endogenous
CaV2.2 channels (data not shown). However, open-state
inactivation of the whole-cell Ba2+ currents is noticeably
faster in pSCM138-transfected neurons than that in
pSCM174-transfected or untransfected neurons. This
is evidenced by the emergence of a pronounced fast in-
activating component in Ba2+ currents recorded from
the majority of pSCM138-transfected neurons (38 of 45
neurons) (Figure 9A), as well as a statistically significant
decrease in average R400 measured from neurons trans-
fected with pSCM138 (Figure 9B). Since channel inacti-
vation is not affected by overexpression of the inactive
mutant peptide (pSCM174), the acceleration of channel
inactivation in pSCM138-transfected neurons is likely
caused by dissociation of endogenous 14-3-3/Ca2+
channel complexes.
Furthermore, we examined how 14-3-3 might regulate
cumulative inactivation of the endogenous CaV2.2
channels in hippocampal neurons, as this property
determines the temporal dynamics of Ca2+ channels in
response to trains of action potentials. In these experi-
ments, whole-cell Ba2+ currents of CaV2.2 channels
were elicited by a train of brief depolarizations. We find
that cumulative inactivation of endogenous CaV2.2
channels is markedly increased in neurons transfectedwith pSCM138, while no difference was observed
between nontransfected and pSCM174-transfected
neurons (Figure 9C). Taken together, these results dem-
onstrate that 14-3-3 is an important regulator of CaV2.2
channel activities in neurons.
14-3-3 Modulates Short-Term Synaptic Plasticity
Having found that 14-3-3 modulates inactivation proper-
ties of CaV2.2 channels in cultured hippocampal neu-
rons, we went on to study its effects on synaptic trans-
missions, especially on short-term synaptic plasticity
in these neurons. In our experiments, two adjacent neu-
rons were whole-cell voltage clamped at a holding
potential of 280 mV. Postsynaptic currents (PSCs) are
elicited by a brief depolarization of the presynaptic neu-
ron. Consistent with previous reports, we find in this cul-
ture both excitatory and inhibitory synapses, which can
be distinguished by the distinct waveforms and reversal
potentials of the postsynaptic responses. Under our re-
cording conditions with 2 mM extracellular [Ca2+], both
excitatory and inhibitory synapses exhibit paired-pulse
depression (PPD), with stronger depression at shorter
interstimulus intervals (ISI) (Kaplan et al., 2003). We
transfected these cultured neurons with either the
14-3-3-binding antagonist pSCM138 or its inactive
mutant control, pSCM174, and recorded pairs of synap-
tically connected neurons in which only the presynaptic
neuron is transfected with the respective construct.
Since both plasmids express EYFP, transfected neurons
were identified by the presence of the green fluores-
cence (Figure 10A). We find that there is a robust in-
crease in paired-pulse depression at synapses in which
the presynaptic neuron is transfected with pSCM138,
but not the mutant control, pSCM174 (Figure 10B). At
100 ms ISI, the paired-pulse ratio (PPR100ms) in
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tic Depression by 14-3-3
(A) Representative image of a low-density
culture of rat hippocampal neurons. Dual re-
cording was made between a pair of trans-
fected, YFP-bearing neurons (presynaptic)
and a nearby untransfected neuron (postsyn-
aptic).
(B) Representative EPSPs recorded from
pairs of neurons in which the presynaptic
neuron was either untransfected (dark trace)
or transfected with either pSCM138 (light
gray trace) or its inactive mutant control,
pSCM174 (gray trace).
(C) Transfection of pSCM138, but not
pSCM174, significantly decreases paired-
pulse ratio evoked by two stimuli delivered
at 100 ms ISI (PPR100ms) (**p < 0.001, ANOVA,
Tukey’s test).pSCM138-transfected excitatory synapses is 0.42 6
0.06, which is significant less than that measured from
control neurons (PPR100ms = 0.70 6 0.04) or synapses
transfected with the mutant pSCM174 (PPR100ms =
0.73 6 0.06) (Figure 10C). Thus, these data reveal
14-3-3’s role in regulating short-term synaptic plasticity
in the central neurons and are consistent with our hy-
pothesis that 14-3-3 inhibits short-term depression by
reducing cumulative inactivation of presynaptic Ca2+
channels.
Discussion
A Protein-Protein Interaction Important for CaV2.2
Channel Function
In this study, we have determined that inactivation prop-
erties of CaV2.2 channels are profoundly modulated by
closely associated 14-3-3 proteins, thus demonstrating
such a regulatory mechanism for CaV2.2 channels. We
expect that our finding may shed some light on the
mechanism underlying the kinetic variability of CaV2.2
channel inactivation observed in different types of neu-
rons (Jones, 2003). Previously, it was suggested that
heterogeneity of b subunits may be responsible for the
diverse kinetic properties of CaV2.2 channels (Scott
et al., 1996). Since channel inactivation is generally ac-
celerated by the three major classes of b subunits (b1,
b3, and b4) expressed in neurons, this mechanism alone
is not sufficient to account for the degree of diversity in
inactivation kinetics of native CaV2.2 channels (Plummer
and Hess, 1991). Our finding, however, provides a meansby which inactivation of CaV2.2 channels can be deceler-
ated. Thus, inactivation kinetics of the CaV2.2 channel is
likely determined by a complex interaction between
14-3-3 and b subunits that can simultaneously bind to
the pore-forming a1B subunit (Figure 2B), and its vari-
ability in different neurons could be the result of several
factors, including variations in expression levels of
14-3-3 and b subunits, the types of b subunits, the iso-
forms of 14-3-3, and the phosphorylation states of the
a1B subunit. In neurons where 14-3-3 binding prevails,
this mechanism could possibly be the basis for the
extremely slow inactivation kinetics in some native
CaV2.2 channels.
Moreover, the temporal dynamics of Ca2+ channels in
response to trains of action potentials is affected by
channel inactivation properties, including Ca2+-depen-
dent inactivation for CaV2.1 and cumulative inactivation
for CaV2.2 channels (Park and Dunlap, 1998; Wittemann
et al., 2000). Recent studies by Xu and Wu have demon-
strated a direct correlation between inactivation of pre-
synaptic CaV2.1 channels and short-term synaptic de-
pression at the calyx-type synapse (Xu and Wu, 2005).
We show here that interference with 14-3-3 bindings
not only accelerates CaV2.2 channel inactivation, but
also enhances short-term depressions in cultured hip-
pocampal neurons. This is consistent with the sugges-
tion that 14-3-3 might regulate short-term synaptic plas-
ticity by modulating presynaptic CaV2.2 channels. On
the other hand, although 14-3-3 proteins are abundant
in the brain, their expressions are specific in certain neu-
rons and regions (Baxter et al., 2002) and are positively
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2002). Thus, 14-3-3-dependent modulation of CaV2.2
channel activity may vary among different types of neu-
rons and/or at various development stages. And such
differential regulation of CaV2.2 channels by 14-3-3
could potentially contribute to the heterogeneity of
short-term synaptic plasticity exhibited at different cen-
tral synapses (Dobrunz and Stevens, 1997).
Mechanism for 14-3-3-Dependent Modulation
of CaV2.2 Channels
We have demonstrated that 14-3-3 modulates CaV2.2
channel inactivation through its bindings to the carboxyl
tail of the pore-forming a1B subunit. Within this region,
we have determined a specific phosphoserine-containing
14-3-3-binding motif and uncovered the existence of
a second putative 14-3-3 interaction site that is function-
ally important for channel regulation (Figure 8F). In our
studies, 14-3-3 binding to the second site was revealed
by coimmunoprecipitations of 14-3-3 with truncated a1B
channel subunits, but not between 14-3-3 and carboxyl
tail fusion proteins (Figures 2D and 8E). This suggests
that the channel protein, when embedded in the plasma
membrane and properly folded, may simply provide a bet-
ter target for 14-3-3 binding compared to a fusion protein
(i.e., the lipid environment, other intracellular regions of
the channel, or possibly even other cellular proteins may
affect 14-3-3 binding). There is a precedent for such an ef-
fect with syntaxin regulation of CaV2.2 channels where the
full-length channel behaves differently from what is ex-
pected from experiments involving fusion proteins (Jarvis
and Zamponi, 2001). However, this disparity also pre-
cluded us fromconducting invitro binding experiments ei-
ther to further define the precise 14-3-3-binding domainor
motif in this region, or to demonstrate a direct 14-3-3 bind-
ing to this site.
Nevertheless, the second putative 14-3-3-binding site
lies close to the region where calmodulin binds to and
profoundly affects inactivation of high voltage-activated
Ca2+ channels (the EF and IQ domains; Figure 3A) (Kim
et al., 2004). In other systems, 14-3-3 is known to affect
calmodulin-dependent functions by either directly inter-
acting with calmodulin (Luk et al., 1999), or competing
with calmodulin for binding to a region where the two
binding sites are in close proximity (Beguin et al.,
2005). In the future, it will be interesting to determine
whether 14-3-3 and calmodulin might cooperatively or
competitively regulate inactivation properties of the
CaV2.2 channel. Considering that 14-3-3-dependent
modulation is specific for the CaV2.2 and CaV2.3 chan-
nels, the two subtypes that exhibit striking similarity in
Ca2+/CaM-dependent regulations (Liang et al., 2003),
such a contention may not be far-fetched.
Implications of 14-3-3’s Function
in the Nervous System
The 14-3-3 proteins were originally isolated from bovine
brains as a group of abundant small (w30 kDa) acidic
proteins (Moore and Perez, 1967). Nearly four decades
after their discovery, the neurophysiological function
of this family of proteins is still not completely known
(Berg et al., 2003). Recent studies from us and others
have established a role for 14-3-3 proteins in regulating
activity and plasma membrane targeting of several clas-ses of neuronal ion channels. It is interesting to note that
recent reports from Hunziker’s group have presented
another mechanism by which 14-3-3 regulates activity
of voltage-dependent Ca2+ channels (Beguin et al.,
2006). They show that, via binding to some members
of the RGK family of Ras-related small G-proteins (e.g.,
Rad), 14-3-3 can relieve the inhibition of Ca2+ channel
activity conferred by Rad. In this system, 14-3-3 func-
tions by competing with Ca2+ channel b subunits for
their binding to Rad, and thus promoting functional
expressions of the Ca2+ channels. Although that mecha-
nism is different from what we reported here, their find-
ing supports 14-3-3’s role as an important regulator of
neuronal Ca2+ channels.
14-3-3 has been implicated in the presynaptic regula-
tion of synaptic transmission and plasticity. In the fruit
fly Drosophila, mutations of 14-3-3z, one of the only two
14-3-3 isoforms, result in a deficit in learning and memory
(Skoulakis and Davis, 1996). Electrophysiological analy-
ses at the neuromuscular junctions reveal that 14-3-3z
mutant flies exhibit impairments in high-frequency trans-
mission fidelity and posttetanic potentiation (Broadie
et al., 1997). In addition, a recent report shows that
14-3-3 is required for a presynaptic form of long-term po-
tentiation (LTP) in the mouse cerebellum (Simsek-Duran
et al., 2004). In this study, we have demonstrated that
14-3-3 decreases short-term synaptic depression in cul-
tured hippocampal neurons, which is likely mediated by
reducing cumulative inactivation of presynaptic CaV2.2
channels. In addition, we show that 14-3-3 binding can
be regulated by specific phosphorylation of the a1B sub-
unit, suggesting that there may be a dynamic regulation
of Ca2+ channel activity by 14-3-3 that is dependent
upon phosphorylation state of the CaV2.2 channel. Con-
sidering that both 14-3-3 and CaV2.2 channels are en-
riched at nerve terminals, it is possible that recurring pre-
synaptic activity might augment this protein-protein
interaction through Ca2+ influx-dependent enhancement
of CaMKII or PKA activity. On the other hand, an increase
in channel/14-3-3 interactions may further enhance Ca2+
influx by reducing CaV2.2 channel inactivation and possi-
bly lead to more 14-3-3 binding to CaV2.2 channels.
Therefore, a dynamically regulated 14-3-3/CaV2.2 chan-
nel protein complex could potentially serve as a positive
feedback mechanism to facilitate synaptic transmissions
and may underlie a presynaptic mechanism for activity-
dependent long-term changes in synaptic transmissions.
Experimental Procedures
cDNA Constructs and Mutagenesis
cDNAs encoding Ca2+ channel subunits including CaV1.2 (a1C),
CaV2.1 (a1A), CaV2.2 (a1B), CaV2.3 (a1E), CaV3.1 (a1G), a2d, and b1b
were generous gifts of Drs. William Catterall (Zhong et al., 2001),
Edward Perez-Reyes, David Yue, and Jian Yang. The a1B cDNA
was subcloned into the bicistronic vector pIRES2-EGFP (Clontech),
and the a2d and b1b cDNAs were cloned into a dual-promoter vector,
pBudCE4.1 (Invitrogen). For expression of GST fusion proteins in
mammalian cells, several regions of the a1B subunit were amplified
by PCR and cloned into the pEBG-1 vector, kindly provided by Dr.
Joseph Avruch (Harvard Medical School). cDNAs encoding various
isoforms of 14-3-3 were generated from a human brain cDNA library
(Clontech) by PCR amplification, and then subcloned into either
pIRES2-EGFP, pEBFP-N1, or pcDNA3 with a C-terminal 1D4 epitope
tag (ETSQVAPA). The plasmids for EYFP-fused doublet of R18
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provided by Dr. Haian Fu (Emory University) (Masters and Fu, 2001).
The truncation mutants of the GST-CT were constructed by intro-
ducing a stop codon into the cDNA at appropriate locations using
the Quickchange strategy (Stratagene). The same approach was
used to introduce site-directed mutations at the CT-pEBG-1. The
S2126A a1B plasmid was constructed by subcloning an S2126A-
containing fragment from the GST-CT cDNA into the wild-type a1B
cDNA. A similar strategy was applied to construct mutant a1B cDNAs
with truncations at various positions of the C-terminal tail. The
chimeric a1 subunit (a1B-CTa1C) was created by replacing the a1B
C-terminal tail (residues 1761–2332) with the corresponding frag-
ment of the a1C subunit (residues 1529–2171) using the XhoI-XbaI
cloning enzymes.
Antibodies, Coimmunoprecipitation, and Western Blot
Two separate polyclonal anti-a1B antibodies were generated and
affinity purified using fusion proteins containing a1B fragments
corresponding to either amino acid residues 1990–2141 of the
carboxyl-terminal domain, or residues 821–1030 of the II-III loop.
The sequence- and phosphorylation-specific antibody anti-pS2126
was generated by immunizing rabbits with a chemically synthesized
peptide containing the phosphorylated S2126 [KQRFY(pS)CDRF
GSREPPQ] (Genemed Synthesis, Inc.) and affinity purified by chro-
matography using the phospho-peptide-coupled CNBr-activated
Sepharose. Anti-GST (Santa Cruz), isoform-specific anti-14-3-3
(Santa Cruz), anti-pan 14-3-3 (Chemicon), and anti-Synapsin I (BD
Transduction Laboratories) were obtained commercially. Anti-1D4
antibody was a generous gift of Dr. Dan Oprian (Brandeis University).
Coimmunoprecipitation of transfected cells was done as
described previously (Zhou et al., 1999). Briefly, tsA 201 cells were
maintained in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum. A calcium phosphate transfection pro-
tocol was used to introduce cDNAs into the cells. Forty-eight hours
after transfections, cells were lysed in lysis buffer containing 1% tri-
ton, 20 mM Tris-HCl (pH 7.5), 10 mM EDTA, 120 mM NaCl, 50 mM
KCl, 50 mM NaF, 2 mM DTT, and protease inhibitors (1 mM PMSF
and 1 mg/ml each of aprotonin, leupeptin, and pepstatin A [Sigma]).
Native tissue lysates were made from crude membrane preparations
of rat brain and pancreas according to standard protocols. After
removing insoluble debris by centrifugation, the clear lysate was
incubated with appropriate antibodies for 2 hr at 4C, and the immu-
nocomplex was precipitated with protein A- or protein A/G-agarose
(Santa Cruz Biotechnology).
Proteins in the cell lysates or immunoprecipitates were separated
on polyacrylamide gels and transferred to nitrocellulose mem-
branes. After blocking with 5% nonfat milk in TBST (0.1% Tween
20 in TBS), the blots were probed with appropriate primary anti-
bodies in blocking buffer at 4C overnight. The membranes were
then washed with TBST and incubated with a 1:3000 dilution of
horseradish peroxidase-conjugated donkey anti-rabbit or sheep
anti-mouse IgG (Amersham) for 1 hr at room temperature. After three
washes of the membrane with TBST and one wash with TBS, protein
complexes were visualized using the enhanced chemiluminescence
(ECL) system (Amersham).
In Vitro Phosphorylation and Binding of GST Fusion Proteins
Phosphorylation of wild-type and mutant GST-2076-2140 by CaMKII
was carried out at 30C for 1 hr in 50 ml reactions containing 2 mg of
purified GST fusion proteins, 50 mM PIPES (pH 7.0), 15 mM MgCl2,
1 mM CaCl2, 50 mg/ml calmodulin, 50 mM ATP, and 50 ng CaMKII
(Calbiochem). Reactions with PKAc were supplemented with
50 mM Tris (pH 7.5), 10 mM MgCl2, and 50 mM ATP. The mixtures
were then added to 2 mg of recombinant 14-3-3g proteins that
were GST purified and thrombin cleaved. Subsequently, 14-3-3
immunoprecipitation and western blot analysis were carried out as
described above.
Neuronal Culture
Cultures of embryonic hippocampal neurons were prepared using
a standard procedure. Briefly, hippocampi were dissected from
E18 embryonic rats (Sprague-Dawley) and digested with papain
for 15 min at 37C. Isolated neurons were plated on poly-D-lysine-
precoated coverslips in appropriate density and cultured inneurobasal Medium (NBM) supplemented with B-27 and 0.5 mM
glutamine at 37C and 5% CO2.
Electrophysiology
To record CaV2.2 channel currents from tsA 201 cells, a calcium
phosphate transfection protocol was used to transfect cells with
cDNAs for major channel subunits including a1B-pIRES2-EGFP
and b1b/a2d-pBudCE4.1, either alone or together with 14-3-3-
pEBFP-N1. At least 2 days after transfection, Ca2+ currents were
recorded from transfected cells in the whole-cell voltage clamp
configuration with an Axopatch 200B amplifier (Axon Instrument).
Ca2+ channels and 14-3-3-cotransfected cells bearing both green
and blue fluorescence were identified with the FITC and BFP filter
sets on an Axiovert 25 inverted fluorescence microscope (ZEISS).
To ensure that BFP tag does not affect 14-3-3’s function, similar ex-
periments were performed by transfecting cells with a1B-pRc/CMV,
b1b/a2d-pBudCE4.1, and 14-3-3-pIRES2-EGFP. Under this condi-
tion, recordings were done from green cells. Patch electrodes with
resistances of 2–4 MU were pulled from borosilicate glass and fire
polished. The pipette solution contained 135 mM CsCl, 10 mM
EGTA, 4 mM Mg-ATP, and 10 mM HEPES (pH 7.5 with CsOH). The
extracellular solution contained 125 mM NaCl, 20 mM BaCl2 (or
10 mM CaCl2), 1 mM MgCl2, and 10 mM HEPES (pH 7.3 with
NaOH). Whole-cell currents were filtered at 1 kHz and digitized at
20 kHz. Data acquisition and analysis were performed with
pCLAMP9 software.
To record endogenous CaV2.2 currents from neurons, cultured
hippocampal neurons were transfected with appropriate cDNAs
after 7–10 days in culture (DIV) using a modified calcium phosphate
transfection protocol (Jiang et al., 2004). At least 2 days after trans-
fection, whole-cell recordings were performed using a method
similar to that for recording from transfected tsA 201 cells. In order
to isolate CaV2.2 channel currents, the bath solution included 1 mM
tetrodotoxin (TTX), 10 mM Nifedepine, and 200 nM u-agatoxin IVA
to block Na+, CaV1, and CaV2.1 channels. Under this condition, the
inward currents were primarily mediated by CaV2.2 channels
(Maeno-Hikichi et al., 2003).
To measure synaptic transmissions in neurons, low-density cul-
tures of hippocampal neurons were transfected with appropriate
cDNAs after 10–14 DIV. Two days after transfection, both the pre-
and postsynaptic neurons were voltage clamped at 280 mV in the
whole-cell configuration. One neuron (presynaptic) was stimulated
by a brief depolarizing pulse (1 ms) to +100 mV; the response was
recorded in the other (postsynaptic) neuron as excitatory postsyn-
aptic currents (EPSC). The bath solution contained 145 mM NaCl,
3 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM glucose, and 10 mM
HEPES (310 mosm, pH 7.3 with NaOH). The pipette solution con-
tained 12.5 mM KCl, 127.5 mM K-gluconate, 10 mM glucose,
1 mM EGTA, 4 mM Mg-ATP, 0.3 mM GTP, and 10 mM HEPES
(290 mM mosm, pH 7.2 with KOH).
Immunocytochemistry
Cultured hippocampal neurons of 14 DIV were fixed with 4% para-
formaldehyde and 4% sucrose in PBS for 10 min, then permeabilized
with 0.25% Triton X-100 in PBS for 5 min. After blocking for 45 min,
the preparation was incubated overnight at 4C with appropriate
antibodies in blocking solution containing 0.1% triton and 10%
goat serum in PBS, followed by incubation with Rhodamine- or
FITC-conjugated secondary antibodies for 2 hr at room tempera-
ture. Images were acquired using fluorescence microscopy on a
Leica DMIRE2. For double-labeling experiments, Rhodamine-conju-
gated anti-mouse and FITC-conjugated anti-rabbit antibodies
(Jackson Labs) were applied together. Fluorescent images were
acquired with an Olympus Fluoview Confocal Scanning System
with an argon ion laser (488 nm) and two HeNe ion lasers (544 nm,
633 nm) plus CCD camera.
Supplemental Data
The Supplemental Data include one supplemental figure and can be
found with this article online at http://www.neuron.org/cgi/content/
full/51/6/755/DC1/.
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